Sequential vs. simultaneous antiretroviral HIV therapy

Huffman, Grace Brooke
November 1998
American Family Physician;11/15/1998, Vol. 58 Issue 8, p1845
Academic Journal
Focuses on how antiretroviral therapy that consists of a combination of two nucleoside analog reverse transcriptase inhibitors can suppress viral load in patients with human immunodefiency virus (HIV) infection. Methods used in the study; Results and discussion; Conclusion.


Related Articles

  • Efficacy and Safety of Emtricitabine vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients: A Randomized Trial. Saag, Michael S.; Cahn, Pedro; Raffi, François; Wolff, Marcelo; Pearce, Daniel; Molina, Jean-Michel; Powderly, William; Shaw, Audrey L.; Mondou, Elsa; Hinkle, John; Borroto-Esoda, Katyna; Quinn, Joseph B.; Barry, David W.; Rousseau, Franck // JAMA: Journal of the American Medical Association;7/14/2004, Vol. 292 Issue 2, p180 

    Context Emtricitabine is a new, once-daily nucleoside reverse transcriptase inhibitor (NRTI) with potent activity against human immunodeficiency virus (HIV). Objective To assess the efficacy and safety of emtricitabine as compared with stavudine when used with a background regimen of didanosine...

  • Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients: A 3-Year Randomized Trial. Gallant, Joel E.; Staszewski, Schlomo; Pozniak, Anton L.; DeJesus, Edwin; Suleiman, Jamal M. A. H.; Miller, Michael D.; Coakley, Dion F.; Lu, Biao; Toole, John J.; Cheng, Andrew K. // JAMA: Journal of the American Medical Association;7/14/2004, Vol. 292 Issue 2, p191 

    Context Tenofovir disoproxil fumarate (DF) is a once-daily nucleotide analogue reverse transcriptase inhibitor. Objective To evaluate the efficacy and safety of tenofovir DF compared with stavudine in antiretroviral-naive patients. Design, Setting, and Participants A prospective, randomized,...

  • Medication therapy among intravenous drug users (IDUs) with HIV infection. Smith, Prince C.; Page, J. Bryan // AIDS Patient Care & STDs;Apr96, Vol. 10 Issue 2, p101 

    Evaluates the use of antiretroviral agents among HIV-positive intravenous drug users (IDU) in Miami, Florida. Medical and social service for HIV-positive IDU; Side effects of antiretroviral agents experienced by IDU; Adherence to medical regimens.

  • Closer, but still no cure. Brink, Susan // U.S. News & World Report;02/16/98, Vol. 124 Issue 6, p73 

    Focuses on the possible impact of an apparent HIV-remission caused by drug therapies in a patient in Germany. Details of the drug combination therapy; Dramatic decrease in the patient's viral load; Evidence of the virus still present in his system; Efforts to develop simple drug regimens.

  • Once-daily darunavir approved for treatmentexperienced adults with HIV.  // British Journal of Hospital Medicine (17508460);Apr2011, Vol. 72 Issue 4, p189 

    The article reports that the European Union (EU) has approved once-daily Prezista (darunavir) tablets in combination with ritonavir for treatment-experienced adults with human immunodeficiency virus (HIV).

  • Combo therapy promising.  // Drug Topics;8/22/94, Vol. 138 Issue 16, p8 

    Reports that combination therapy with zidovudine, zalcitabine and saquinavir is more effective that a two-drug regimen in reducing blood levels of the human immunodeficiency syndrome virus.

  • New Class Of Drug Against HIV Gets Accelerated Approval.  // RN;Jun2003, Vol. 66 Issue 6, p94 

    Reports on the U.S. Food and Drug Administration's approval of a class of drug for use in combination with other agents to treat advanced HIV-1 infection. Fusion inhibition mechanism of the drug; Possible side effects.

  • Darunavir in the Treatment of HIV-1 Infection. Holodniy, Mark // Drugs;2007, Vol. 67 Issue 18, p2803 

    This article comments on the study in this issue which looked at the use of darunavir in the treatment of HIV-1 infections. It is recommended that HIV-positive people undergo combination therapy from two drug classes and while the combination therapy has resulted in suppression of viral...

  • Malaria and HIV: demystifying the often misunderstood relationship. Brieger, William R. // Africa Health;Jul2011, Vol. 33 Issue 5, p14 

    The article explores the relationship between malaria and HIV/AIDS. It was found that there is a biological interaction in people who are co-infected with both diseases. It emphasizes that co-infections have the tendency to increase HIV viral load in population with acute malaria. It stresses...

  • Quantifying the activity of anti-HIV treatment in silico. Ribeiro, Ruy M // Nature Medicine;Mar2012, Vol. 18 Issue 3, p355 

    An introduction to the journal is presented in which the author discusses an article on the combination of three antiretroviral drugs for anti-HIV treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics